PMID: 16634373Apr 26, 2006Paper

Mycophenylate mofetil: what role in the treatment of lupus?

Lupus
Mary Anne Dooley

Abstract

Improved patient survival following lupus nephritis with the institution of corticosteroids, immunosuppressants and renal replacement therapy allows greater emphasis on long-term management issues. In particular, the recent focus has been on therapies to treat nephritis with fewer adverse effects of cyclophosphamide-including immunosuppressive regimens. Mycophenolate mofetil (MMF) has been used in the field of transplantation for more than 10 years. Following initial anecdotal reports describing benefits of MMF in the treatment of lupus nephritis, randomized, controlled trials have established a role for MMF in the treatment of lupus nephritis. MMF use to treat other lupus manifestations has been evaluated only in anecdotal case reports or series with few well-designed trials. Issues complicating clinical trial design in lupus including appropriate use and interpretation of activity and damage indices, comparable remission and response criteria and stratification of high risk populations have been the subject of much discussion and emerging consensus. As long-term outcomes in lupus improve, the toxicity of therapy and risk of relapse become increasingly important determinants of choice of therapeutic agents.

References

Mar 6, 1986·The New England Journal of Medicine·H A AustinJ L Decker
Apr 15, 1999·Journal of the American Society of Nephrology : JASN·M A DooleyL A Hebert
Jun 26, 2001·Journal of the American Academy of Dermatology·S Goyal, H C Nousari
Jul 9, 2002·The British Journal of Dermatology·S SchanzG Fierlbeck
May 22, 2003·Annals of the Rheumatic Diseases·M BijlC G M Kallenberg
Aug 28, 2003·Southern Medical Journal·Ahmed S Samad, Carol B Lindsley
Feb 14, 2004·Rheumatology·P P KapitsinouH M Moutsopoulos
Mar 5, 2004·The New England Journal of Medicine·Gabriel ContrerasDavid Roth
Aug 17, 2004·Annals of the Rheumatic Diseases·K Ahmadi-SimabW L Gross
Feb 25, 2005·Journal of the American Society of Nephrology : JASN·Tak-Mao ChanUNKNOWN Hong Kong Nephrology Study Group
Nov 25, 2005·The New England Journal of Medicine·Ellen M GinzlerGerald B Appel
Oct 17, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Ximena VelásquezSergio Jacobelli

❮ Previous
Next ❯

Citations

Nov 14, 2007·International Journal of Clinical Practice·J Ermann, B L Bermas
Apr 28, 2007·Expert Opinion on Investigational Drugs·Umut SelametLorraine Harper
Jan 20, 2009·Journal of the American Academy of Dermatology·Alissa K OrvisShannon W Watkins
Feb 10, 2007·Autoimmunity Reviews·Luca IaccarinoAndrea Doria
Oct 4, 2007·Annals of the New York Academy of Sciences·Luca IaccarinoAndrea Doria

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Chee-Seng Yee, Caroline Gordon
The New England Journal of Medicine
Ellen M GinzlerGerald B Appel
Lancet
David P D'CruzGraham R V Hughes
© 2022 Meta ULC. All rights reserved